Clin2
NCT07600450Worth exploringRecruiting

First study of a new drug in healthy adults

Kidney Disease

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests a new investigational drug to see how safe it is and how the body processes it. It is one of the first steps in drug development, and it helps determine if the drug is suitable for further testing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
25 years to 55 years
Study type
Interventional

Who can take part

  • You are between 25 and 55 years old.
  • You weigh at least 110 lbs (50 kg) for men or 99 lbs (45 kg) for women.
  • Your body mass index (BMI) is between 18 and 28.
  • You are of Chinese, Japanese, or White/European ancestry with specific family history.
  • You are generally healthy with no major medical conditions.
  • You are not currently taking certain medications or have taken experimental drugs recently.
  • You are willing to stay in the study for about 8 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07046559Recruiting· Phase 1
Testing a new drug's safety in healthy volunteers

This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.

Holbeck, Leeds
NCT07745907Recruiting· Phase 1
A first-in-human study of a new drug in healthy Chinese and Japanese adults

This trial tests a single dose of an investigational drug called AMG 691 in healthy Chinese and Japanese volunteers to see how it is processed by the body and how safe it is. This is an early-phase study, so it may help make future treatments safer for people of similar backgrounds.

Las Vegas, Nevada
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07789899Recruiting· Phase 1
Safety study of a new investigational drug in healthy volunteers

This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.

Cambridge
NCT07748702Not yet recruiting· Phase 1
Study of a new drug in healthy volunteers

This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.

Seoul
NCT07473323Recruiting· Phase 1
Testing a new drug for healthy adults and those with diabetic kidney disease

This trial tests a new medication called MTX-439. It includes healthy adults and people with diabetic kidney disease to see if the drug is safe and to learn how the body handles it.

Melbourne, Victoria

Hear when a new Kidney Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.